19 May, 2022
Watch the recording for this RQM+ Live! show and learn why the MDR / IVDR labeling requirements are a great opportunity to start with a blank slate and achieve global market compliance.
RQM+ Live! is an interactive live show featuring expert panelists discussing timely topics, challenges, and solutions in the medical device and diagnostics industries. The panelists also answer your questions live! Every episode is added to our podcast, too.
---
Medical device and IVD labeling has always been a challenge for manufacturers because updates are often required when new regulations are introduced. With the piecemeal approach that is commonly taken, the result is a product box covered in labels or inconsistent language and placement across product lines. This can be confusing and overwhelming for end users.
With the implementation of MDR and IVDR requiring significant labeling revisions, manufacturers should consider it an opportunity to start with a blank slate to both achieve global market compliance and eliminate duplicate and inconsistent information.
The reality is that labels will always need to be updated, and manufacturers need processes and systems for:
Director, Clinical Compliance, Multinational Medical Device Manufacturer
©2024 RQM+ All Rights Reserved | Cookies Policy | Privacy Statement